This manuscript reports on the application of ribosome profiling (EZRA-seq and eRF1-seq) combined with massively parallel reporter assays to identify and characterize a GA-rich element associated with ...
FDA Type 2a meeting scheduled for November 19, 2025, to review AEON's analytical development plan and initial data - - Positive biosimilarity data for ABP-450 confirming identical amino-acid sequencin ...
In addition to these results, the Company will soon commence a drilling program on the Quebec portion of the Pense claim group. This program aims to investigate strong electromagnetic (EM) anomalies ...
The battle against HIV in sub-Saharan Africa has always been as much about systems and science as about the virus itself. Antiretroviral therapy has turned what was once a death sentence into a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback